Delivery Order SPE2DB22D3501-SPE2DB24FVC82
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S. The contract has a ceiling value of $3,331.45 and a period of performance ending on May 28, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of pharmaceutical products, specifically YUVAFEM 10 MCG VAGINAL INSERT 18S, to support military treatment programs and facilities. The award has a ceiling value of $2,402.77 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp holds an indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, with a ceiling value of $1,427.93 and a completion date of May 23, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,396.56, is for the supply of a single pharmaceutical product, YUVAFEM 10 MCG VAGINAL INSERT 18S. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product, with a ceiling value of $4,460.99 and a performance period through July 2, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product, with a ceiling value of $1,488.72 and a completion date of July 11, 2025. The contract is a firm-fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 18 units of the drug YUVAFEM 10 MCG VAGINAL INSERT. The contract has a total ceiling value of $2,495.58 and a completion date of June 12, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of YUVAFEM 10 MCG vaginal inserts. The contract award has a ceiling value of $4,563.32 and an ultimate completion date of August 23, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product, with a ceiling value of $2,261.23 and an ultimate completion date of June 17, 2025. The contract is a firm fixed-price delivery order, and is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product YUVAFEM 10 MCG VAGINAL INSERT 18S. The contract has a firm fixed price of $2,111.40 and a completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, to provide a comprehensive range...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVC82Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product. The delivery order has a ceiling value of $1,781.67 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order in this summary was issued against that overarching IDC. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 4/2/24 |